Skip to content
The Nexus
DossierENTITY

expanded access program

Coverage of expanded access program in the Nexus archive.

Earliest in view: Jun 4 · 17:15 UTCMost recent: Jun 4 · 17:15 UTC
Co-mentioned in this coverage
Amy Johnstonperson1pancreatic cancertopic1daraxonrasibtopic1Revolution Medicinesorganization1Gilbertsville, Paplace1
Recent coverage
  • HEALTHJun 4 · 17:15 UTCSTAT NEWS
    STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach

    Amy Johnston, a pancreatic cancer patient, is participating in a clinical trial for daraxonrasib, a drug that nearly doubled survival time in trials. Revolution Medicines is offering the drug via an expanded access program, but patients face anxiety over supply shortages and prioritization.

expanded access program · Dossier · The Nexus